Ultragenyx Drug Patent Portfolio
Ultragenyx owns 1 orange book drug protected by 2 US patents Given below is the list of Ultragenyx's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8697748 | Glycogen or polysaccharide storage disease treatment method | 28 Apr, 2029 | Active |
| US9186344 | Glycogen or polysaccharide storage disease treatment method | 01 Jul, 2025 | Expired |
Latest Legal Activities on Ultragenyx's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ultragenyx.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Term Extension Certificate
Critical
| 17 Oct, 2023 | US8697748 |
| Notice of Final Determination -Election Required | 06 Jun, 2023 | US9186344 |
| Notice of Final Determination -Election Required | 06 Jun, 2023 | US8697748 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 May, 2023 | US9186344 |
|
FDA Final Eligibility Letter
Critical
| 29 Aug, 2022 | US8697748 |
|
FDA Final Eligibility Letter
Critical
| 29 Aug, 2022 | US9186344 |
| transaction for FDA Determination of Regulatory Review Period | 05 Nov, 2021 | US9186344 |
| transaction for FDA Determination of Regulatory Review Period | 05 Nov, 2021 | US8697748 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Oct, 2021 | US8697748 |
| Second letter to regulating agency to determine regulatory review period | 20 May, 2021 | US8697748 |
| Second letter to regulating agency to determine regulatory review period | 20 May, 2021 | US9186344 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US9186344 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US8697748 |
| Initial letter Re: PTE Application to regulating agency | 13 Nov, 2020 | US8697748 |
| Initial letter Re: PTE Application to regulating agency | 13 Nov, 2020 | US9186344 |
Ultragenyx's Family Patents
Ultragenyx Drug List
Given below is the complete list of Ultragenyx's drugs and the patents protecting them.
1. Dojolvi
Dojolvi is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8697748 | Glycogen or polysaccharide storage disease treatment method |
28 Apr, 2029
(3 years from now)
| Active |
| US9186344 | Glycogen or polysaccharide storage disease treatment method |
01 Jul, 2025
(6 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dojolvi's drug page